Valor Management LLC

Institutional investor · Portfolio as of Q3 2024

Q3 2024 biggest moves
  • RDDTRDDT

    Reddit

    Sold out

    was 19% of portfolio

  • ANROANRO

    Alto Neuroscience

    Sold out

    was 0.4% of portfolio

4 changes in all

Top Holdings4 positions

Checking export access…
Activity:
HRMY

Harmony Biosciences Holdings, Inc.

11.2M$448.7M94.5%$42.64-6.19%
12 qtrssince 2021-Q4
Unchanged
0
ALAB

Astera Labs, Inc.

446,189$23.4M4.9%$74.19+78.53%
3 qtrssince 2024-Q1
Unchanged
0
SONDQ
SONDQDelisted

SONDER HOLDINGS INC

476,321$2.2M0.5%——
5 qtrssince 2023-Q3
Unchanged
0
BIOA

BioAge Labs, Inc.

13,105$272,5840.1%$20.800.00%
1 qtr
New
35
$474.6M
AUM
4
Positions
Q3 2024
Filing
HI rating · 1.5/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2023-Q2$401,639,3005.77073261002%
2023-Q3$371,545,052-7.49285440942%
2023-Q4$363,964,641-2.04024006219%
2024-Q1$479,566,64231.7618768357%
2024-Q2$454,745,175-5.17581183222%
2024-Q3$474,598,9284.3659073458%
Activity profile
$ moved · Q3'24
New<1%Increased0%Decreased0%Exited>99%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q25%1-4Q25%1-2Y25%2Y+25%

Valor Management LLC manages $474.6M across 4 positions as of Q3 2024. Top holdings: HRMY (94.5%), ALAB (4.9%), SONDQ (0.5%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Top holdings by portfolio weight

Total AUM$475M
HRMY94.55%
ALAB4.93%
SONDQ0.47%
BIOA0.06%
GETR0.00%
ANRO0.00%
RDDT0.00%

Portfolio allocation by GICS sector

Sectors3
Healthcare94.60%
Technology4.93%
Consumer Cyclical0.47%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L18
Conviction71
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used